DRW Securities LLC acquired a new stake in Semrush Holdings, Inc. (NASDAQ:SEMR – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,000 shares of the company’s stock, valued at approximately $157,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Jacobs Levy Equity Management Inc. acquired a new stake in Semrush in the 1st quarter valued at $543,000. VELA Investment Management LLC acquired a new stake in shares of Semrush in the third quarter valued at about $701,000. Cubist Systematic Strategies LLC purchased a new stake in shares of Semrush during the second quarter worth about $3,006,000. Renaissance Technologies LLC acquired a new position in shares of Semrush during the 2nd quarter worth about $3,732,000. Finally, SG Americas Securities LLC purchased a new position in Semrush in the 2nd quarter valued at about $654,000. 32.86% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, Director Dmitry Melnikov sold 64,140 shares of the company’s stock in a transaction on Wednesday, September 18th. The stock was sold at an average price of $14.59, for a total value of $935,802.60. Following the transaction, the director now owns 9,227,898 shares of the company’s stock, valued at $134,635,031.82. This represents a 0.69 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Vitalii Obishchenko sold 55,000 shares of Semrush stock in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $13.43, for a total transaction of $738,650.00. Following the sale, the chief operating officer now owns 848,923 shares of the company’s stock, valued at approximately $11,401,035.89. This represents a 6.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 154,112 shares of company stock worth $2,179,734. Insiders own 57.83% of the company’s stock.
Semrush Stock Down 3.0 %
Wall Street Analyst Weigh In
Several equities research analysts have commented on SEMR shares. The Goldman Sachs Group boosted their price objective on Semrush from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Monday, October 7th. JPMorgan Chase & Co. boosted their price target on Semrush from $16.00 to $17.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Needham & Company LLC restated a “buy” rating and issued a $18.00 price objective on shares of Semrush in a report on Monday, November 11th. Finally, KeyCorp upped their target price on shares of Semrush from $19.00 to $21.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $16.50.
Get Our Latest Stock Report on SEMR
Semrush Company Profile
Semrush Holdings, Inc develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally. The company enables companies to identify and reach the right audience for their content through the right channels. Its platform enables the company's customers to understand trends and act upon insights to enhance the online visibility, and drive traffic to their websites and social media pages, as well as online listings, distribute targeted content to their customers, and measure the digital marketing campaigns.
Further Reading
- Five stocks we like better than Semrush
- What is the FTSE 100 index?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Roth IRA Calculator: Calculate Your Potential Returns
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- High Flyers: 3 Natural Gas Stocks for March 2022
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Semrush Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semrush and related companies with MarketBeat.com's FREE daily email newsletter.